MarketPulse

brain health

3 articles
BenzingaBenzinga··Globe Newswire

Angelini Pharma Acquires Catalyst for $4.1B, Marking Bold U.S. Market Entry

Angelini Pharma to acquire Catalyst Pharmaceuticals for $4.1 billion in all-cash deal, marking entry into U.S. market and strengthening rare disease focus.
CPRXacquisitionM&A
GlobeNewswire Inc.GlobeNewswire Inc.··Michael French

Stroke Prevention Takes Center Stage as AHA Targets 80% Preventable Cases Annually

American Heart Association highlights that 80% of strokes are preventable. With 800,000 Americans affected annually, early recognition and risk management could reshape cardiovascular care economics.
HCAemergency responsebrain health
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

T. Rowe Price CEO Joins Longeviti Board as Neurotech Firm Scales AI Brain Health Platform

T. Rowe Price CEO Robert W. Sharps joins Longeviti Neuro Solutions' board, bringing three decades of asset management expertise to support the AI-driven neurotechnology company's growth.
TROWartificial intelligencecorporate governance